Niagen Bioscience, Inc. Common Stock
Symbol: NAGE (NASDAQ)
7.47
▲ (0.50%) 0.037
Company Description:
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Key Stats
- Today's Open: $7.35
- Today's High: $7.57
- Today's Low: $7.315
- Today's Volume: 276.38K
- Yesterday Close: $7.43
- Yesterday High: $7.51
- Yesterday Low: $7.17
- Yesterday Volume: 1.10M
- Last Min Volume: 64
- Last Min High: $7.475
- Last Min Low: $7.471
- Last Min VWAP: $7.47398
Company Profile
- Name: Niagen Bioscience, Inc. Common Stock
- Website: https://www.niagenbioscience.com
- Listed Date: 2008-06-24
- Location: LOS ANGELES, CA
- Market Status: Active
- CIK Number: 0001386570
- SIC Code: 2833
- SIC description: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
- Market Cap: $598.94M
- Round Lot: 100
- Outstanding Shares: 79.75M
- Asset Type: CS
RECENT FILINGS FOR NAGE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-06 | 8-K | View |
| 2025-08-08 | S-8 | View |
| 2025-08-08 | S-8 | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | 10-Q | View |
| 2025-07-29 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-05-07 | 8-K | View |
| 2025-05-07 | 10-Q | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-09 | 4 | View |
Latest News on NAGE